A lower starting dosage of reboxetine should be given to patients with hepatic impairment

Source: Inpharma, Volume 1, Number 1240, 2000 , pp. 19-19(1)

Publisher: Adis International

Keywords: Reboxetine, pharmacokinetics; Antidepressants, pharmacokinetics; Liver-failure

Language: English

Document Type: Research article

Links for this article

http://www.ingentaconnect.com/adis/inp/2000/00000001/00001240/art00017
http://openurl.ingenta.com/content?genre=article&issn=11738324&volume=1&issue=1240&spage=19&epage=19